Macro Dragon: Trump, RBA, Powell, Lagarde... & count-down to Wed's VP Debate

Macro Dragon: Trump, RBA, Powell, Lagarde... & count-down to Wed's VP Debate

Macro 4 minutes to read
Kay Van-Petersen

Global Macro Strategist

Summary:  Macro Dragon = Cross-Asset Daily Views that could cover anything from tactical positioning, to long-term thematic investments, key events & inflection points in the markets, all with the objective of consistent wealth creation overtime.


(These are solely the views & opinions of KVP, & do not constitute any trade or investment recommendations. By the time you synthesize this, things may have changed.)

Macro Dragon: Trump, RBA, Powell, Lagarde... + Wed's VP Debate

 

Top of Mind…

  • Touched on this wk in the Dragon’s New Month = New & Final Quarter = New POTUS piece

  • Worth noting that the key Final Service PMIs yest generally came in stronger than expected with final EZ in at 48.0a 47.6e/p (yet obviously in contraction territory being sub 50), UK 56.1a 55.1e, US 54.6a/e & US ISM Serv. PMI 57.8a 56.3e 56.9p (again US data still holding up!)

  • Today we got a few key things including RBA rate decision, as well as ECB’s Lagarde (@ 16:35 & @ 21:00 SGT) & Fed’s Powell (@ 22:40 SGT) set to speak at different events

  • Tomorrow will be all about the VP debate – naturally viewed as that much more pivotal, with Trumps’ health status likely to be in a state of Limbo until at least 2H of Oct

  • In regards to Trump’s tweet last Fri on having contracted Covid-19 – biggest likely change from the Dragon’s view is that the probability of fiscal deal prior to the election has gone up

  • By no means a done deal or even significantly above 50%, yet aesthetics of POTUS catching the virus are likely Net-Negative from the republican camp… its not going to be a Bojo sympathy theme. This could force the Republicans to be more open to getting to an agreement with the Democrats. Obviously one can argue if it really makes any difference, with votes already coming in… yet hard to see when US politics has been rational over the last few years

  • Its worth noting with Trump that we are likely not going to know just how bad a state he will be in, until midway this wk to end of the wk. If you recall Bojo was first at home, ordering curries & dropping jokes… then needed to be rushed to hospital.

  • Whilst the dominant press coverage on Trump is rarely net positive, its does seem pretty clear that the updates from the Doctors have been with a positive spin & a lot of questions are being dodged. It’s also worth noting Trump seems to be on steroids – which traditionally are only given to folks who are really in bad shape around covid – as well as a number of other prototype cocktail of drugs.

  • He is back in the White House, yet still under full care - & whilst his car drive publicity stunt has been criticized , clearly he was still well enough to do that. Again real MtM on his health is likely to be seen before mid Oct.

  • CNN Cut: Trump returns to White House and removes mask despite having Covid

  • Fox Cut: Trump discharged from Walter Reed, returns to White House

  • From what KVP can gather, the cleanest pathway in the scenario of Trump falling to Covid-19 or in someway being incapacitated is that Pence becomes the de facto face of the Republican Ballot. And it almost surely raises the delta of the Dragon’s contrarian (yet changing consensus view post the debate last wk), view that this is going to be a blue tsunami  

  • Either way – one thing that few people seem to be keeping in mind, is that no one is talking about upside risk. And on election night – despite ballots that will still need to be counted (our understanding is they have to wait for election night to open the mailed votes) –  we may have a scenario where it mathematically impossible for one candidate to catch up to another, due to the loss of a number of the key swing states

  • So pay special attention again to the likes of Florida, Wisconsin, Pennsylvania & Minnesota

  • As always anything is possible… yet current feel is that most folks are on the side-lines, with a potential net-short bias on equities & folks worried about election uncertainty

  • That could change very quickly if we have a highly probable clear winner on/very close to election day – i.e. short-squeeze, to relief rally given uncertainty & big event-risk being cleared, as well as anticipation of a new administration getting the next fiscal bill in order  

-

Not Caught Enough of KVP?

-

Dragon's Must Reads

John Hardy dropping a roadmap US Election Primer: The Final Sprint to November 3rd

We sort through important dates in this final sprint phase of the absurdly long US presidential election cycle. Historically, we have seen significant shifts in the polling in the final weeks leading up to the election. As well, we consider factors that can change the odds between now and Election Day on November 3rd.

Saxo’s US Election Cheat Sheet Which cuts into the three potential pathways into the elections, probabilities around them, as well as short & long-term positions across equities, bonds, commodities & currencies.

-

Start-to-End = Gratitude + Integrity + Vision + Tenacity | Process > Outcome | Sizing > Idea

This is the way 

KVP

Quarterly Outlook

01 /

  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

  • FX outlook: Tariffs drive USD strength, until...?

    Quarterly Outlook

    FX outlook: Tariffs drive USD strength, until...?

    John J. Hardy

    Global Head of Macro Strategy

  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer for more details.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992